Related Experiment Video
Updated: Nov 24, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Role of lncRNA LUCAT1 in cancer
Ce Xing1, Shou-Gang Sun1, Zhi-Quan Yue1
1Lanzhou University Second Hospital, Department of Cardiology, 82 Cuiying Men, Lanzhou, 730030, PR China.
Abstract:
Long non-coding RNAs (lncRNAs) are RNA molecules with a transcript length of more than 200 nt and lack a protein-coding ability. They regulate gene expression by interacting with protein, RNA, and DNA. Their function is closely related to their subcellular localization. In the nucleus, lncRNAs regulate gene expression at the epigenetic and transcriptional levels, and in the cytoplasm, they regulate gene expression at the post-transcriptional and translational levels. Abnormalities in lncRNAs have been confirmed to exhibit tumor suppressor or carcinogenic effects and play an important role in the development of tumors. In particular, the lung cancer-related transcript 1 (LUCAT1) located in the antisense strand of the q14.3 region of chromosome 5 was first discovered in smoking-related lung cancer. Increasing evidence have showed that LUCAT1 is involved in breast cancer, ovarian cancer, thyroid cancer, renal cell carcinoma. It is highly expressed in liver cancer and other malignant tumors and has been confirmed to be induce various malignant tumors. It regulates tumor proliferation, invasion, and migration via various mechanisms and is related to the clinicopathological characteristics of tumor patients. Thus, LUCAT1 is a potential prognostic biological marker and therapeutic target for cancer. This article reviews its expression, function, and molecular mechanism in various malignant tumors.
Insights
Long non-coding RNAs (lncRNAs) regulate gene expression and are implicated in cancer development. The lung cancer-related transcript 1 (LUCAT1) is a key player in various malignancies, acting as a potential biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are crucial regulators of gene expression at epigenetic, transcriptional, post-transcriptional, and translational levels.
- Dysregulation of lncRNAs is linked to tumor suppressor or carcinogenic effects, impacting tumor development.
- Lung cancer-related transcript 1 (LUCAT1), identified in smoking-related lung cancer, is implicated in multiple cancers.
Purpose of the Study:
- To review the expression, function, and molecular mechanisms of LUCAT1 in various malignant tumors.
- To highlight LUCAT1's role in tumor proliferation, invasion, and migration.
- To establish LUCAT1 as a potential prognostic biomarker and therapeutic target for cancer.
Main Methods:
- Literature review of studies on LUCAT1 expression and function in cancer.
- Analysis of LUCAT1's molecular mechanisms in regulating tumor progression.
- Correlation analysis of LUCAT1 with clinicopathological characteristics.
Main Results:
- LUCAT1 is highly expressed in liver cancer and other malignant tumors, inducing various cancers.
- LUCAT1 influences tumor proliferation, invasion, and migration through diverse mechanisms.
- LUCAT1 expression correlates with clinicopathological features of cancer patients.
Conclusions:
- LUCAT1 is a significant oncogenic lncRNA involved in the development and progression of multiple cancers.
- LUCAT1 exhibits potential as a prognostic biomarker and a therapeutic target for cancer treatment.
- Further research into LUCAT1's mechanisms can inform novel cancer therapies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...